Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1612 with DOI

1 strong · 9 moderate · 6 weak

Compilations

12026-05-03T16:53:16.956Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

30last ruled 2026-06-04

0 awaiting a ruling

Issued documents

42026-10-19T20:31:45.933Z

notice · info card · emergency

Searches

192 with no results

queries and counts on the build

Claims checked

6942 supported

42 supported · 27 not

Correspondence

0received

consent field ships in Phase 4

Edges

216

derivations recorded for this entity

Complete over 16 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/ephenidine/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-09-24srcLefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS
  3. 2026-09-24srcDiphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn, and LC-HR-MSn
  4. 2026-09-24src1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
  5. 2026-09-24srcLefetamine, a controlled drug and pharmaceutical lead of new designer drugs: synthesis, metabolism, and detectability in urine and human liver preparations
  6. 2026-09-24srcPharmacological characterizations of the 'legal high' fluorolintane and isomers
  7. 2026-09-24srcEphenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
  8. 2026-09-24srcToxicokinetics of lefetamine and derived diphenylethylamine designer drugs—Contribution of human cytochrome P450 isozymes to their main phase I metabolic steps
  9. 2026-09-24srcHair Analysis of Methoxphenidine in a Forensic Chemsex Case
  10. 2026-09-24srcMethoxphenidine Use Disorder: First Case Notified to the French Addictovigilance Network
  11. 2026-09-24srcEphenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network
  12. 2026-09-24srcDeaths related to the use of diarylethylamines, with a focus on the United Kingdom: A systematic review and case series report
  13. 2026-09-24srcPharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues
  14. 2026-09-24srcWHO 43rd ECDD Summary Assessment and Recommendations — Diphenidine review
  15. 2026-09-24srcEnantiomeric separation of diphenidine-derived new psychoactive substances (NPS) by polar organic chiral high-performance liquid chromatography
  16. 2026-09-24srcThe Misuse of Drugs Act 1971 (Amendment) Order 2024 (SI 2024/190)
  17. 2026-09-24srcACMD Review of the Evidence on the Use and Harms of Diphenidine
  18. 2026-09-04issueIssued emergency
  19. 2026-09-04issueIssued info_card
  20. 2026-09-04issueIssued notice
  21. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  22. 2026-06-04publicationPublication — backfill
  23. 2026-05-03revisionRevision 1
  24. 2026-05-03absenceSearched ClinicalTrials.gov for "ephenidine" — no results
  25. 2026-05-03absenceSearched ClinicalTrials.gov for "ephenidine" — no results
  26. 2026-05-03genGeneration — pipeline-v5pipeline-v5
  27. 2026-05-03rungeneration run

The same entries, as forms: six forms.